Intended for UK and IE residentsPrescribing information and adverse event reporting can be found at bottom of page
Welcome to strengthofbalance.co.uk
This website contains information that is intended for healthcare professionals and budget holders for healthcare organisations only. Please click on one of the buttons below to ensure you are directed to the most relevant content.
By clicking this link, you are leaving the www.strengthofbalance.co.uk website and entering a third party website. Galapagos is not responsible for the content and management of third party websites.
Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click 'Continue', otherwise click 'Stay on page'.
Glossary
ALC, absolute lymphocyte count
ANC, absolute neutrophil count
ACR, American College of Rheumatology
AE, adverse event
CDAI, Clinical Disease Activity Index
CRP, C-reactive protein
csDMARD, conventional synthetic disease-modifying anti-rheumatic drug
DAS28-CRP, Disease Activity Score 28 joints
EAIR, exposure-adjusted incidence rate
Hb, haemoglobin
IR, inadequate response or intolerance to
JAK, Janus kinase
JAKi, Janus kinase inhibitor
MACE, major adverse cardiac event
MOA, mechanism of action
mTSS, modified Total Sharp Score
MTX, methotrexate
NMSC, non-melanoma skin cancer
PY, patient-years
PYE, patient-year exposure
RA, rheumatoid arthritis
SDAI, Simplified Disease Activity Index
STAT, signal transducer and activator of transcription
TYK, tyrosine kinase
UTI, urinary tract infection
URTI, upper respiratory tract infection
VTE, venous thromboembolism